about
Can pluripotent stem cells be used in cell-based therapy?Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII.Recombinant glycoprotein production in human cell lines.Production of coagulation factor VII in human cell lines Sk-Hep-1 and HKB-11.Approaches for recombinant human factor IX production in serum-free suspension cultures.Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines.OP9 Stromal Cells Proteins Involved in Hematoendothelial Differentiation from Human Embryonic Stem Cells.Murine leukemia virus-derived retroviral vector has differential integration patterns in human cell lines used to produce recombinant factor VIII.Forced expression of OCT4 influences the expression of pluripotent genes in human mesenchymal stem cells and fibroblasts.Production of recombinant coagulation factors: Are humans the best host cells?SK-HEP cells and lentiviral vector for production of human recombinant factor VIII.Human hepatic stellate cell line (LX-2) exhibits characteristics of bone marrow-derived mesenchymal stem cells.Stable and high-level production of recombinant Factor IX in human hepatic cell line.Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells.Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia.Pluripotent Reprogramming of Fibroblasts by Lentiviralmediated Insertion of SOX2, C-MYC, and TCL-1AHematopoietic stem cells from induced pluripotent stem cells – considering the role of microRNA as a cell differentiation regulatorPatent mining and landscaping of emerging recombinant factor VIII through network analysisEmerging CAR T cell therapies: clinical landscape and patent technological routes
P50
Q27002327-BE633481-5259-4939-AD45-508C051614CFQ30471522-87994FCF-AC70-42AE-A8A6-2469DC4FE69AQ38275231-2AA3B357-83FC-4BC0-9FAA-FFFEFE8768C0Q38698983-7762DBF4-B389-4A37-9301-26D8C4B27820Q38819734-B7AB83D0-E0DF-4C3C-B8EE-187F7055C96CQ38913136-0741E96C-FDD6-485A-BA23-5487CF3EFB15Q38972094-AFB1C135-37D4-4C24-BE61-E454054136CDQ38974765-E06C45E2-4B9F-4382-88E9-FD44C019D047Q39161518-32FE613B-E0C7-40F1-8465-06A7BF41D3ECQ39170433-1161AD9D-7C30-4CB0-9422-E9E44ED3A475Q39367231-18C03366-AAD4-4830-898D-B35E49C3F2ECQ39471795-C418B356-B8B0-4AA4-98AB-2EB88E2E4ACAQ39490991-44F46B25-70F1-4381-9E1E-06396EB39630Q39660444-524AE069-1554-441F-80DD-6792FB025367Q41320530-489D386E-C338-4D01-B698-D75B88087DDBQ56787015-D62A1C2D-E62C-4036-9DCB-AD5723613505Q58855550-14DDADF3-A215-4F4B-841D-2C25A962ABC9Q89445046-CB062133-8AD2-4919-B21D-FC868BA0D547Q91186129-CB158B21-D03E-4127-995B-DCA5A622B7BC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Virginia Picanco-Castro
@ast
Virginia Picanco-Castro
@en
Virginia Picanco-Castro
@es
Virginia Picanco-Castro
@nl
type
label
Virginia Picanco-Castro
@ast
Virginia Picanco-Castro
@en
Virginia Picanco-Castro
@es
Virginia Picanco-Castro
@nl
prefLabel
Virginia Picanco-Castro
@ast
Virginia Picanco-Castro
@en
Virginia Picanco-Castro
@es
Virginia Picanco-Castro
@nl
P106
P2038
Virginia_Picanco
P21
P31
P496
0000-0001-8474-4610